Product Information

GRISEOFULVIN 125 MG/5 ML SUSP is a generic product labeled by Chartwell RX LLC, priced at $0.2287 per ML under NDC 62135096841. Its NADAC has been published 246 times since Nov 10, 2021.

FDA first approved this application on Mar 2, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GRISEOFULVIN 125 MG/5 ML SUSP

Griseofulvin (microsize)
$0.2287per ML

Strength

125 mg/5mL

Manufacturer

Chartwell RX LLC

NDC

62135096841

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

GRISEOFULVIN

Approval Type

Generic (ANDA)

FDA Application

ANDA065200

FDA Approved

3/2/2005

TE Code

AB

On Market Since

3/2/2005

Pharmacological Classes

Decreased Mitosis
Microtubule Inhibition
Tubulin Inhibiting Agent

Price Statistics

The NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has been published 246 times since Nov 10, 2021, and over the history we have for it it has declined 13.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2287 per ML
All-time high$0.4099 (Dec 13, 2023)
All-time low$0.2115 (Nov 17, 2021)
52-week high$0.2686
52-week low$0.2287
Median price$0.3075
Average price$0.3209
Largest weekly change-19.8% (Nov 17, 2021)
Weeks tracked246
Tracking sinceNov 10, 2021

Price History

1W

-7.2%

1M

-9.3%

3M

-9.2%

6M

-10.5%

1Y

-14.9%

3Y

-44.2%

5Y

+8.1%

All

-13.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Griseofulvin (microsize) market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GRISEOFULVIN 125 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for GRISEOFULVIN 125 MG/5 ML SUSP, manufactured by Chartwell RX LLC, is $0.2287 per ML (NDC 62135096841), effective Nov 18, 2026.

How has the price of GRISEOFULVIN 125 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has declined 13.3%. It has been tracked across 246 weekly CMS publications since Nov 10, 2021.

What are the highest and lowest recorded NADAC prices for GRISEOFULVIN 125 MG/5 ML SUSP?

Since Nov 10, 2021, the NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has ranged from a low of $0.2115 (Nov 17, 2021) to a high of $0.4099 (Dec 13, 2023), with a median of $0.3075 per ML.

Are there cheaper alternatives to GRISEOFULVIN 125 MG/5 ML SUSP?

No other NADAC-published product currently shares the active ingredient and strength of GRISEOFULVIN 125 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GRISEOFULVIN 125 MG/5 ML SUSP?

GRISEOFULVIN 125 MG/5 ML SUSP (NDC 62135096841) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.